Attana invited to present at the The Austrian-Russian Biopharma Club in Mosoc November 19th

The Austrian-Russian Biopharma Club will be held on November 19, 2019, as part of the the Second Moscow Molecular Allergology Meeting (MMAM).  The meeting will unite research organizations with major manufacturers in the biopharma industry. Attana is invited to present our cell-based technology and succesful applications.

As part of HVD Life Sciences network Attana is invited to present at the Austrian-Russian Biopharma Club. Attana's CEO Teodor Aastrup will present examples on how Attanas tchnology can be applied in Allergy research with a particular focus on Attana's cell-based and sera-based applications.

For more information, please contact:

Teodor Aastrup, CEO Attana AB
tel: + 46 8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share prices, but is of general interest for the shareholders and hence should be communicated.

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit or contact